Page last updated: 2024-11-02

phenobarbital and Diabetic Ketoacidosis

phenobarbital has been researched along with Diabetic Ketoacidosis in 1 studies

Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.

Diabetic Ketoacidosis: A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and extreme HYPERGLYCEMIA. It is characterized by KETOSIS; DEHYDRATION; and depressed consciousness leading to COMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bock, JL1

Other Studies

1 other study available for phenobarbital and Diabetic Ketoacidosis

ArticleYear
Analysis of serum by high-field proton nuclear magnetic resonance.
    Clinical chemistry, 1982, Volume: 28, Issue:9

    Topics: Acidosis; Adult; Aged; Blood Chemical Analysis; Blood Glucose; Diabetic Ketoacidosis; Ethanol; Human

1982